Experimental CRISPR technique has promise against aggressive leukaemia
New ScientistMAR 14 2023
The outcome of this revolutionary treatment is remarkable, and makes base editing a strong contender in the development of innovative cell and gene therapies. With trials for curing single-cell diseases already underway, the next step is for the biomedical community to develop a versatile, cost-effective program to make base editing cures a reality for millions of patients worldwide.
Though base editing might have saved Alyssa's life, it's too early to guess her prognosis. Furthermore, considering that the treatment can permanently change a patient's genetic code, every effort must be made to identify and address ethical issues that may arise with its use, such as the privacy and confidentiality of genomic data.